How is the InMed Pharmaceuticals Inc today?

The InMed Pharmaceuticals Inc today is trading in the green, up by 9.06% at 3.25.

What is InMed Pharmaceuticals Inc Annual Revenue?

InMed Pharmaceuticals Inc Annual Revenue rose 11.18%, in the last year to $4.6 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is InMed Pharmaceuticals Inc Annual Net Profit?

InMed Pharmaceuticals Inc Annual Net Profit rose 3.42% in the last year to $7.68 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is InMed Pharmaceuticals Inc Price to Earning Ratio?

InMed Pharmaceuticals Inc Price to Earning Ratio is -0.47, which is negative.

What is InMed Pharmaceuticals Inc Stock Price?

InMed Pharmaceuticals Inc Stock Price fell 43.97% and underperformed its sector by 71.25% in the past year.

What is InMed Pharmaceuticals Inc Quarterly Revenue?

InMed Pharmaceuticals Inc Quarterly Revenue rose 7.59% YoY to $1.26 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is InMed Pharmaceuticals Inc Quarterly Net profit?

InMed Pharmaceuticals Inc Quarterly Net profit fell 23.1% YoY to $2.12 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is InMed Pharmaceuticals Inc Debt to Equity Ratio?

InMed Pharmaceuticals Inc Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is InMed Pharmaceuticals Inc Return on Equity(ROE)?

InMed Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -72.08%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is InMed Pharmaceuticals Inc Institutional Holding?

InMed Pharmaceuticals Inc Institutional Holding decreased by 3.16% in the last quarter to 1.57.

InMed Pharmaceuticals Inc XNAS: INM

InMed Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: InMed Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: InMed Pharmaceuticals Inc
Rating: 1.79858325
Author: Trendlyne DVM scores

about

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio in...

3.25 0.27 (9.06%)

79.30% Fall from 52W High

162.8K XNAS Volume

High vol.+gain this week

XNAS 05 Jun, 2025 10:20 AM (EDT)

Not Eligible

-

Expensive Valuation

29.3 / 100

Technically Neutral

42.6 / 100

No estimates available

InMed Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

InMed Pharmaceuticals Inc FAQ

How is InMed Pharmaceuticals Inc today?

InMed Pharmaceuticals Inc today is trading in the green, and is up by 9.06% at 3.25.

How has InMed Pharmaceuticals Inc performed historically?

InMed Pharmaceuticals Inc is currently trading up 9.06% on an intraday basis. In the past week the stock rose 23.57%. stock has been up 23.11% in the past quarter and fell -43.97% in the past year. You can view this in the overview section.